Wolkenstein P - Search Results

1

Facial Scars following Toxic Epidermal Necrolysis: Role of Adnexal Involvement?

Habre M, Ortonne N, Colin A, Meningaud JP, Chosidow O, Wolkenstein P, Valeyrie-Allanore L. Habre M, et al. Among authors: wolkenstein p. Dermatology. 2016;232(2):220-3. doi: 10.1159/000443164. Epub 2016 Feb 12. Dermatology. 2016. PMID: 26866828

2

Drug-induced toxic epidermal necrolysis.

Wolkenstein PE, Roujeau JC, Revuz J. Wolkenstein PE, et al. Clin Dermatol. 1998 May-Jun;16(3):399-408. doi: 10.1016/s0738-081x(98)00011-x. Clin Dermatol. 1998. PMID: 9642534 Review. No abstract available.

3

Prospective evaluation of risk factors of cutaneous drug reactions to sulfonamides in patients with AIDS.

Eliaszewicz M, Flahault A, Roujeau JC, Fillet AM, Challine D, Mansouri S, Wolkenstein P, Aractingi S, Penso-Assathiany D, Maslo C, Bourgault-Villada I, Chosidow O, Caumes E; Epitox Study Group. Eliaszewicz M, et al. Among authors: wolkenstein p. J Am Acad Dermatol. 2002 Jul;47(1):40-6. doi: 10.1067/mjd.2002.120468. J Am Acad Dermatol. 2002. PMID: 12077579

4

Association analysis of drug metabolizing enzyme gene polymorphisms in AIDS patients with cutaneous reactions to sulfonamides.

Wolkenstein P, Loriot MA, Flahault A, Cadilhac M, Caumes E, Eliaszewicz M, Beaune P, Roujeau JC, Chosidow O; Epitox Group. Wolkenstein P, et al. J Invest Dermatol. 2005 Nov;125(5):1080-2. doi: 10.1111/j.0022-202X.2005.23939.x. J Invest Dermatol. 2005. PMID: 16297214 Free article. No abstract available.

5

Poor reporting of quality of life outcomes in dermatology randomized controlled clinical trials.

Le Cleach L, Chassany O, Levy A, Wolkenstein P, Chosidow O. Le Cleach L, et al. Among authors: wolkenstein p. Dermatology. 2008;216(1):46-55. doi: 10.1159/000109358. Dermatology. 2008. PMID: 18032899

6

[Phacomatosis].

Valeyrie-Allanore L, Wolkenstein P. Valeyrie-Allanore L, et al. Among authors: wolkenstein p. Rev Prat. 2008 Apr 15;58(7):717-24. Rev Prat. 2008. PMID: 18546640 Review. French.

7

Repair of the lower and middle parts of the face by composite tissue allotransplantation in a patient with massive plexiform neurofibroma: a 1-year follow-up study.

Lantieri L, Meningaud JP, Grimbert P, Bellivier F, Lefaucheur JP, Ortonne N, Benjoar MD, Lang P, Wolkenstein P. Lantieri L, et al. Among authors: wolkenstein p. Lancet. 2008 Aug 23;372(9639):639-45. doi: 10.1016/S0140-6736(08)61277-5. Lancet. 2008. PMID: 18722868

8

Differential expression of CCN1/CYR61, CCN3/NOV, CCN4/WISP1, and CCN5/WISP2 in neurofibromatosis type 1 tumorigenesis.

Pasmant E, Ortonne N, Rittié L, Laurendeau I, Lévy P, Lazar V, Parfait B, Leroy K, Dessen P, Valeyrie-Allanore L, Perbal B, Wolkenstein P, Vidaud M, Vidaud D, Bièche I. Pasmant E, et al. Among authors: wolkenstein p. J Neuropathol Exp Neurol. 2010 Jan;69(1):60-9. doi: 10.1097/NEN.0b013e3181c79bff. J Neuropathol Exp Neurol. 2010. PMID: 20010302

9

Bacteremia in Stevens-Johnson syndrome and toxic epidermal necrolysis: epidemiology, risk factors, and predictive value of skin cultures.

de Prost N, Ingen-Housz-Oro S, Duong TA, Valeyrie-Allanore L, Legrand P, Wolkenstein P, Brochard L, Brun-Buisson C, Roujeau JC. de Prost N, et al. Among authors: wolkenstein p. Medicine (Baltimore). 2010 Jan;89(1):28-36. doi: 10.1097/MD.0b013e3181ca4290. Medicine (Baltimore). 2010. PMID: 20075702 Free article.

10

Cutaneous macroglobulinosis: a report of 2 cases.

Gressier L, Hotz C, Lelièvre JD, Carlotti A, Buffet M, Wolkenstein P, Bagot M, Melica G, Ortonne N. Gressier L, et al. Among authors: wolkenstein p. Arch Dermatol. 2010 Feb;146(2):165-9. doi: 10.1001/archdermatol.2009.359. Arch Dermatol. 2010. PMID: 20157027

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

467 results

Search Page

Filters